1.
International Journal of Laboratory Medicine
;
(12)2006.
Artigo
em Chinês
| WPRIM
| ID: wpr-528047
RESUMO
Objective To evaluate the relationship of thrombin activated fibrinolysis inhibitor (TAFI) in plasma with changes of coagulant and fibrinolytic function in type 2 diabetes.Methods The plasma level of TAFI was measured by ELISA, fibrinogen was analyzed with Clauss assay and plasminogen was detected by chromogenic assay.Results The plasma levels of TAFI, Fib and the activity of PLG were significantly increased in type 2 diabetes with (P